GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Windlas Biotech WINDLAS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

974.25

-2.03%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹9.04bn

FY2018FY2026

Net income

₹664.6m

FY2018FY2026

Free cash flow

₹337.7m

FY2018FY2026

Shareholders' equity

₹5.81bn

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue₹9.04bn₹7.60bn₹6.29bn₹5.11bn₹4.63bn₹4.27bn₹3.28bn₹3.05bn₹3.52bn
Research and development₹83.4m₹62.5m₹78.8m₹89.5m₹65.1m₹36.1m₹38.7m₹41.9m₹19.6m
Operating income₹788.3m₹841.4m₹782.0m₹578.3m₹469.8m₹434.1m₹325.2m₹342.9m₹224.7m
Net income₹664.6m₹609.9m₹581.9m₹426.3m₹380.9m₹158.3m₹162.1m₹638.2m₹112.0m
Diluted earnings per share31.3228.6627.5720.5017.547.268.9130.085.28

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets₹9.07bn₹7.60bn₹6.26bn₹5.29bn₹4.91bn₹2.96bn₹3.38bn₹2.98bn₹2.90bn
Cash and short-term investments₹2.70bn₹2.40bn₹2.04bn₹1.32bn₹1.76bn₹542.5m₹406.6m₹341.0m₹300.5m
Total liabilities₹3.27bn₹2.55bn₹1.76bn₹1.27bn₹962.3m₹970.0m₹1.29bn₹1.05bn₹1.65bn
Debt₹352.4m₹326.0m₹36.4m₹49.9m₹66.4m₹323.5m₹289.3m₹318.5m₹574.3m
Shareholders' equity₹5.81bn₹5.06bn₹4.50bn₹4.02bn₹3.95bn₹1.99bn₹2.10bn₹1.94bn₹1.25bn
Shares outstanding21m21m21m21m22m22m18m21m21m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations₹1.01bn₹681.9m₹1.09bn₹609.6m₹91.3m₹114.5m₹250.1m₹186.5m₹295.9m
Capital spending−₹676.6m−₹521.9m−₹376.8m−₹708.9m−₹148.0m−₹58.5m−₹153.1m−₹89.5m−₹257.8m
Free cash flow₹337.7m₹159.9m₹712.8m−₹99.3m−₹56.7m₹56.1m₹97.0m₹97.0m₹38.1m
Dividends paid−₹121.6m−₹115.0m−₹83.0m−₹76.3m−₹76.3m————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹2.48bn₹2.38bn₹2.33bn₹2.22bn₹2.10bn₹2.03bn₹1.95bn₹1.87bn
Operating income₹194.7m₹172.9m₹166.8m₹209.6m₹190.8m₹172.1m₹176.9m₹165.5m
Net income₹176.5m₹159.9m₹150.0m₹178.0m₹176.6m₹162.8m₹155.8m₹156.6m
Diluted earnings per share8.327.547.058.368.307.657.387.42
Cash from operations———₹559.0m————
Capital spending———−₹293.0m————
Free cash flow———₹266.0m————
Total assets—₹9.07bn—₹8.14bn—₹7.60bn—₹7.47bn
Cash and short-term investments₹2.79bn₹2.70bn₹2.61bn₹2.61bn₹2.39bn₹2.40bn₹2.13bn₹2.13bn
Debt—₹330.9m—₹278.3m—₹303.5m—₹170.9m
Shareholders' equity₹5.81bn₹5.81bn₹5.34bn₹5.34bn₹5.06bn₹5.06bn₹4.71bn₹4.71bn

Financial ratios

Data as of 29 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin8.7%11.1%12.4%11.3%10.1%10.2%
Net margin7.4%8.0%9.3%8.3%8.2%3.7%
Return on equity11.4%12.1%12.9%10.6%9.6%8.0%
Return on assets7.3%8.0%9.3%8.1%7.8%5.3%
Free cash flow yield7.3%5.2%6.3%5.8%1.0%0.7%
Revenue growth19.0%20.8%23.2%10.2%8.6%29.9%
Earnings growth9.0%4.8%36.5%11.9%140.6%-2.3%
Current ratio1.95x2.11x2.51x2.92x4.06x2.08x
Debt to equity0.06x0.06x0.00x0.00x0.02x0.16x
Equity ratio64.0%66.5%71.9%76.0%80.4%67.2%
Interest coverage16.33x19.20x70.77x73.38x33.16x33.65x
R&D as a share of sales0.9%0.8%1.3%1.8%1.4%0.8%
Buybacks as a share of market value0.3%-0.8%-1.5%4.3%0.5%-19.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.0%16.2%—
Operating income10.9%12.7%—
Net income16.0%33.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings28.527.737.820.914.238.1
Price to sales2.12.23.51.81.21.4

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 21 Jul 2025.

FY2026FY2025FY2024FY2023
Paid in the year5.805.504.003.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.